| 2D Structure | |
| CID | 60662 |
| IUPAC Name | [(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate;dihydrochloride |
| InChI | InChI=1S/C29H38FN3O3.2ClH/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26;;/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32);2*1H/t28-,29-;;/m0../s1 |
| InChI Key | MTJLQTFHJIHXIX-GDUXWEAWSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C29H40Cl2FN3O3 |
| Molecular Weight | 568.5 |
| synonyms | ['Mibefradil dihydrochloride', '116666-63-8', 'Mibefradil hydrochloride', 'RO 40-5967/001', '842TUP3PQ8', 'DTXSID8044204', 'Ro-40-5967/001', 'DTXCID6024204', '(1S,2S)-(2-((3-(2-Benzimidazolyl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate, dihydrochloride', 'Acetic acid, methoxy-, 2-(2-((3-(1H-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1S-cis)-', '(1S,2S)-[2-[[3-(2-Benzimidazolyl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate, dihydrochloride', 'RefChem:158484', '848-218-2', 'Posicor', 'MIBEFRADIL 2HCL', 'Ro 40-5967', 'MFCD00881804', 'Mibefradil dihydrochloride [USAN]', 'Mibefradil-dihydrochloride', 'Acetic acid, 2-methoxy-, (1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, hydrochloride (1:2)', 'Mibefradil (dihydrochloride)', '[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate;dihydrochloride', 'NCGC00094089-01', '(1S,2S)-2-(2-((3-(1H-benzo[d]imidazol-2-yl)propyl)(methyl)amino)ethyl)-6-fluoro-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate dihydrochloride', 'Mibefradil dihydrochloride (USAN)', 'Mibefradil Dihydrochloride (>90%)', 'Mibefradil HCl', '(1S,2S)-2-(2-{[3-(1H-1,3-benzodiazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate dihydrochloride', 'CAS-116666-63-8', 'UNII-842TUP3PQ8', 'Posicor (TN)', 'Cerate 50', 'C29H40Cl2FN3O3', 'SCHEMBL120810', 'Ro 40-5967 dihydrochloride', 'orb1309424', 'CHEMBL1534525', 'SCHEMBL29412446', 'Miberadil Dihydrochloride Hydrate', 'EX-A2252', 'Tox21_111244', 'Tox21_500748', 'FD5011', 'HB1226', 'HY-15553A', 'AKOS017343957', 'Tox21_111244_1', 'CCG-222052', 'CS-1189', 'FM65086', 'LP00748', 'MIBEFRADIL DIHYDROCHLORIDE [MI]', 'MIBEFRADIL HYDROCHLORIDE [MART.]', 'MIBEFRADIL HYDROCHLORIDE [WHO-DD]', 'NCGC00161420-06', 'NCGC00261433-01', 'Ro-40-5967', '[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate dihydrochloride', 'AC-35842', 'AS-75317', 'FM178653', 'MIBEFRADIL DIHYDROCHLORIDE [VANDF]', 'Mibefradil dihydrochloride; Ro 40-5967', 'SY128967', 'EU-0100748', 'D05024', 'M 5441', 'SR-01000075997', 'SR-01000075997-1', 'Q27269476', '(1S,2S)-2-(2-{[3-(1H-1,3-Benzimidazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl methoxyacetate--hydrogen chloride (1/2)', '(1S,2S)-2-[2-[[3-(2-Benzimidazolyl)propyl](methyl)amino]ethyl]-6-fluoro-1-isopropyl-1,2,3,4-tetrahydro-2-naphthyl 2-Methoxyacetate Dihydrochloride', '[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methyl-amino]ethyl]-6-fluoro-1-isopropyl-tetralin-2-yl] 2-methoxyacetate;dihydrochloride', '[(1S,2S)-2-[2-[3-(1H-Benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-isopropyl-tetralin-2-yl] 2-methoxyacetate dihydrochloride', 'Ro 40-5967; (1S,2S)-2-[2[[3-(2-benzimidazolylpropyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride'] |
From Pubchem